妊娠期糖尿病:改善母婴健康的机会
妊娠期糖尿病是妊娠期最常见的医学疾病,与妊娠并发症及母婴长期代谢风险增加相关。本文总结妊娠期糖尿病女性及其子代长期风险的证据,提出需从短期状况转向可改变的长期状况的思维转变,并探讨改善临床实践的方法及未来研究重点。
要点
- 妊娠期糖尿病与妊娠并发症及母婴长期代谢风险增加相关。
- 当前指南主要关注妊娠和分娩期短期风险,仅Carpenter-Coustan标准基于产后2型糖尿病风险。
- 需要从短期状况思维转向可改变的长期状况思维,以应对儿童肥胖和心血管代谢疾病负担。
核心结论
- 需要转变对妊娠期糖尿病的认识,从增加巨大儿风险的短期状况转向可能导致女性及后代儿童肥胖和心血管代谢疾病负担加重的可改变的长期状况。
研究设计与样本
- 本文为个人观点(Personal View)文章,总结妊娠期糖尿病女性及其子代长期风险的证据,提出改善临床实践的建议并列出未来研究重点。
主要发现
- 妊娠期糖尿病与妊娠并发症增加及女性及其子代长期代谢风险相关。
- 当前国家和国际指南推荐的诊断和管理策略主要关注妊娠和分娩期间的短期风险,但Carpenter-Coustan标准基于妊娠期糖尿病后未来2型糖尿病发病风险。
关键数值与推荐
- Carpenter-Coustan标准基于妊娠期糖尿病后未来2型糖尿病发病风险。
临床怎么用
- 作者建议需要转变对妊娠期糖尿病的思维,从短期状况转向可改变的长期状况,并提出改善当前临床实践的方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gestational diabetes, the most common medical disorder in pregnancy, is defined as glucose intolerance resulting in hyperglycaemia that begins or is first diagnosed in pregnancy. Gestational diabetes is associated with increased pregnancy complications and long-term metabolic risks for the woman and the offspring. However, the current diagnostic and management strategies recommended by national and international guidelines are mainly focused on short-term risks during pregnancy and delivery, except the Carpenter-Coustan criteria, which were based on the risk of future incidence of type 2 diabetes post-gestational diabetes. In this Personal View, first, we summarise the evidence for long-term risk in women with gestational diabetes and their offspring. Second, we suggest that a shift is needed in the thinking about gestational diabetes; moving from the perception of a short-term condition that confers increased risks of large babies to a potentially modifiable long-term condition that contributes to the growing burden of childhood obesity and cardiometabolic disorders in women and the future generation. Third, we propose how the current clinical practice might be improved. Finally, we outline and justify priorities for future research.
引用
- Saravanan P. Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol. 2020. PMID: 32822601. doi:10.1016/S2213-8587(20)30161-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。